February 19, 2025

FDA Approves Amneal’s Lenalidomide; Mesalamine 800 mg Launched

Mesalamine 800 mg delayed-release tablets have been launched, and FDA approval has been granted for lenalidomide, with plans for entry into the U.S. generic market in 2026.

Conexiant

February 17, 2025

Broccoli Sprout Extract in Prediabetes: Microbiota and Glycemic Variability

Researchers examined the effects of broccoli sprout extract on fasting glucose in prediabetes and observed variability in glycemic response potentially linked to microbiota composition.

Conexiant

February 14, 2025

Study: Patients Trust Female Docs Less

Study findings and an interview with the lead investigator.

Conexiant

February 13, 2025

IBD & Associated Heart Disease: Men at Higher Risk

Men with IBD have nearly double the risk of developing ischemic heart disease compared to those without the condition, while females with IBD exhibit a lower risk.

Conexiant

February 12, 2025

FDA Clears Rapid GI Test Panel for Gastroenteritis Detection

Clearance was granted to bioMérieux's BIOFIRE FILMARRAY GI Panel Mid, a 1-hour molecular test that can detect 11 common gastroenteritis-causing pathogens from a single stool sample.

Conexiant

February 10, 2025

Dupilumab for Pediatric EoE: Phase III Histologic Remission Findings

Researchers found that dupilumab improved histologic remission in pediatric patients with eosinophilic esophagitis.

Conexiant

February 10, 2025

GLP-1 RA Reinitiation Rates Lower for Patients Without T2D, Study Finds

Researchers analyzed glucagon-like peptide-1 receptor agonist discontinuation and reinitiation trends. They found higher discontinuation rates among patients without type 2 diabetes and identified weight loss, adverse events, and cost as associated factors.

Conexiant

February 07, 2025

FDA Approves Novel Antibiotic for cIAI

FDA approves aztreonam-avibactam, the first monobactam/β-lactamase inhibitor combination antibiotic, for treating complicated intra-abdominal infections in adults with limited treatment options.

Conexiant

February 06, 2025

GI Issues? Ask About Tick Bites

"A diagnosis of AGS should be strongly considered in patients with a history of tick bites and clinical presentation of allergic or GI manifestations."

Conexiant